Loading...
Images of Roberto Latagliata
(0 from 0 )1
0
0
News
onkoserv - der aktuellste und unabhängige deutsche Informationsdienst...
www.onkoserv.de
Onkoserv ist der aktuellste deutsche Informationsdienst für die klinische Onkologie
Network Profiles
LinkedIn: Roberto Latagliata | LinkedIn
Visualizza il profilo professionale di Roberto Latagliata su LinkedIn. LinkedIn è la rete professionale più grande al mondo utilizzata dai professionisti come ...
Maria Antonietta Aloe Spiriti | AceMap
acemap.openacademic.ai
Massimo Breccia, Maria Teresa Voso, Luca Maurillo, Pasquale Niscola, Luana Fianchi, Maria Antonietta Aloe Spiriti, Francesco Buccisano, Roberto Latagliata Biological Activity of Lenalidomide in Myelodysplastic Syndromes With Del5q Results of Gene Expression Profiling From A Multicenter Phase Ii Study.
Business Profiles
Researchgate: Roberto Latagliata
Rome, Italy
Education
Eltrombopag versus placebo for low-risk myelodysplastic syndromes...
kclpure.kcl.ac.uk
... Carluccio and Francesco Buccisano and Voso, {Maria Teresa} and Stefano Mancini and Austin Kulasekararaj and Fortunato Morabito and Monica Bocchia and Patrizia Cufari and Spiriti, {Maria Antonietta Aloe} and Irene Santacaterina and D'Errigo, {Maria Grazia} and Irene Bova and Gina Zini and Roberto Latagliata",.
Books & Literature
Roberto Latagliata | XanEdu Customization Platform
www.academicpub.com
Author: Roberto Latagliata. Results. Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile ...
LONG-TERM FOLLOW-UP OF PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA
library.ehaweb.org
Access educational materials, eLearning activities, accredited Live webinar sessions with polls and chat on this fast Digital Library and Hybrid Virtual Event...
PULMONARY INFECTIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
library.ehaweb.org
Instantly find & access educational materials and complete eLearning activities at your leisure. Native iPad/iPhone/Android Apps are available for the...
Related Documents
Adding Hydroxyurea to Imatinib is Effective in Patients with Chronic...
benthamopen.com
Adding Hydroxyurea to Imatinib is Effective in Patients with Chronic My-elogenous Leukemia Resistant to Imatinib Alone
CiteSeerX — bloodjournal.hematologylibrary.org at PENN STATE...
citeseerx.ist.psu.edu
BibTeX @MISC{Latagliata02bloodjournal.hematologylibrary.orgat, author = {Roberto Latagliata and Maria Concetta Petti and Susanna Fenu and Marco Mancini and Maria
[PDF] Europass Curriculum Vitae - Free Download PDF
silo.tips
Breccia, Giuliana Alimena, Francesco Nobile, Roberto Latagliata (2012). . ANNALS OF HEMATOLOGY2012, p. 1-8, ISSN: , doi: s HCV infection, B-cell non-Hodgkin's lymphoma and immunochemotherapy: Evidence and open questions. Cox MC, Aloe-Spiriti MA, Cavalieri E, Alma E, ...
EBSCOhost | | Early hospital discharge with oral...
web.b.ebscohost.com
Roberto Latagliata & Sergio Mecarocci &. Salvatore Giacomo Morano & Caterina Stefanizzi &. Giuliana Alimena. Received: 18 October Accepted:
Scientific Publications
Acute myeloid leukemia in the elderly: ‘per aspera ad astra’? -...
www.sciencedirect.com
Acute myeloid leukemia in the elderly: 'per aspera ad astra'?☆. Roberto Latagliata. x. Roberto Latagliata. Search for articles by this author ...
Delayed cytogenetic and major molecular responses associated to...
www.sciencedirect.com
Daniela Diverio, Roberto Latagliata, Giuliana Alimena. Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy. a r t i c l e i n f o. Article history: Received 21 September Received in revised form 12 November Accepted 6 December Keywords: Chronic myeloid leukemia.
Frontline Dasatinib Treatment in a “Real-Life” Cohort of Patients...
www.sciencedirect.com
Frontline Dasatinib Treatment in a “Real-Life” Cohort of Patients Older than 65 Years with Chronic Myeloid Leukemia. Roberto Latagliata. x. Roberto Latagliata. Search for articles by this author ...
Publications
Erratum to: Second-Generation Tyrosine Kinase Inhibitors in...
link.springer.com
Erratum to: Second-Generation Tyrosine Kinase Inhibitors in First-Line Treatment of Chronic Myeloid Leukaemia (CML) ... Roberto Latagliata (3) Author Affiliations. 1.
Oalib search
www.oalib.com
Abstract: Background: Imatinib has become first line therapy in chronic myeloid leukemia patients. Little is known about the infective ...
Immunophenotyping of acute myeloid leukaemia: Relevance of analysing...
link.springer.com
Roberto Latagliata (1) Bruno Monarca (1) Giulio De Rossi (1) Author Affiliations. 1. Haematology Section, Human Biopathology Department, University “La Sapienza
Early hospital discharge with oral antimicrobial therapy in patients...
link.springer.com
Although consensus exists relating criteria for the identification of low-risk patients with febrile neutropenia, no clear indication on how to manage thes
Reports & Statements
Rebel Legion :: Viewing profile
www.forum.rebellegion.com
Realname: Roberto Latagliata. E-mail address: Private Message: Send private message. MSN Messenger: Yahoo Messenger: AIM Address: ICQ Number: ...
Miscellaneous
Roberto Latagliata | Profilo professionale - LinkedIn
www.linkedin.com
Visualizza il profilo di Roberto Latagliata su LinkedIn, la più grande comunità professionale al mondo. Roberto ha 2 offerte di lavoro sul suo profilo. Guarda il profilo completo su LinkedIn e scopri i collegamenti di Roberto e le offerte di lavoro presso aziende simili.
Roberto Latagliata | LinkedIn
www.linkedin.com
View Roberto Latagliata's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Roberto Latagliata discover
A POPULATION-BASED STUDY ON MYELODYSPLASTIC SYNDROMES IN THE LAZIO...
www.mjhid.org
Flavia Mayer, Laura Faglioni, Nera Agabiti, Susanna Fenu, Francesco Buccisano, Roberto Latagliata, Roberto Ricci, Maria Antonietta Aloe Spiriti, Caterina Tatarelli, Massimo Breccia, Giuseppe Cimino, Luana Fianchi, Svitlana Gumenyuk, Stefano Mancini, Luca Maurillo, Carolina Nobile, Pasquale Niscola, ...
Efficacy of prolonged therapy with combined arsenic trioxide and ATRA...
haematologica.org
Massimo Breccia 1 ⇓, Laura Cicconi 1, Clara Minotti 1, Roberto Latagliata 1, Laura Giannì 2 and ; Francesco Lo-Coco 1; 1 Department of Cellular Biotechnologies and
FLT3-ITD confers poor prognosis in patients with acute promyelocytic...
haematologica.org
Roberto Latagliata 1, ... & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org.
Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk...
www.growkudos.com
Francesca Palandri, Mario Tiribelli, Giulia Benevolo, Alessia Tieghi, Francesco Cavazzini, Massimo Breccia, Micaela Bergamaschi, Nicola Sgherza, Nicola Polverelli, Monica Crugnola, Alessandro Isidori, Gianni Binotto, Florian H. Heidel, Francesco Buccisano, Bruno Martino, Roberto Latagliata, Marco Spinsanti, Lydia ...
WikiGenes -
www.wikigenes.org
... Elena Elli, Alessandra Iurlo, Roberto Latagliata, Francesca Lunghi, Monia Lunghi, Rosa Maria Marfisi, Pellegrino Musto, Arianna Masciulli, Caterina Musolino, ...
EARLY AND LATE COMPLICATIONS RELATED TO CENTRAL VENOUS CATHETERS IN...
www.mjhid.org
EARLY AND LATE COMPLICATIONS RELATED TO CENTRAL VENOUS CATHETERS IN HAEMATOLOGICAL MALIGNANCIES: A RETROSPECTIVE ANALYSIS OF PATIENTS
Revised International Prognostic Scoring System (IPSS) Predicts...
hwmaint.jco.ascopubs.org
Maria Teresa Voso, Susanna Fenu, Roberto Latagliata, Francesco Buccisano, Alfonso Piciocchi, Maria Antonietta Aloe-Spiriti, Massimo Breccia,
Early hemorrhagic death before starting therapy in acute...
haematologica.org
Massimo Breccia, Roberto Latagliata, Laura Cannella, Clara Minotti, Giovanna Meloni, Francesco Lo-Coco. Haematologica May : ; ...
Latagliata febb 15
www.accademia-lancisiana.it
... in termini di sopravvivenza quando posto a confronto in 2 studi randomizzati al placebo o al miglior trattamento disponibile. U. RECINE, Direttore U.O.C. Medicina Interna, Ospedale Santo Spirito in Sassia, Roma. Roberto Latagliata: Dipartimento di Biotecnologie Cellulari ed Ematologia, “Sapienza” Università di Roma.
Erratum to: Second-Generation Tyrosine Kinase Inhibitors in...
www.infona.pl
... Kinase Inhibitors in First-Line Treatment of Chronic Myeloid Leukaemia (CML). more. less. Elisabetta Abruzzese, Massimo Breccia, Roberto Latagliata.
Ematologia La Sapienza
www.ematologialasapienza.org
Sito ufficiale del Dipartimento di Ematologia dell'Univesità degli studi di Roma La Sapienza
Clinical and biological features of acute promyelocytic leukemia...
haematologica.org
Massimo Breccia, Roberto Latagliata, Ida Carmosino, Laura Cannella, Daniela Diverio, Anna Guarini, Maria Stefania De Propris, Maria Concetta Petti, Giuseppe ...
Evaluation of comorbidities at diagnosis predicts outcome in...
read.qxmd.com
Massimo Breccia, Vincenzo Federico, Roberto Latagliata, Caterina Mercanti, Gianna Maria D'Elia, Laura Cannella, Giuseppina Loglisci, Adriano Salaroli, ...
The dose and the duration of frontline therapy with imatinib does not...
f1000research.com
... Antonio Cuneo, Roberto Latagliata, Felicetto Ferrara, Alessandro Isidori
Hemoglobin levels and circulating blasts are two easily evaluable...
www.infona.pl
Roberto Latagliata. Department of Cellular Biotechnology and Hematology, University of Rome “Sapienza”, Italy ...
Health and Diseases Information - Part 2
www.triplechealthcare.com
According to the study authors, Dr. Roberto Latagliata from La Sapienza University in Rome and colleagues said that their findings showed the severe and ...
Imatinib in Very Elderly Patients with Chronic Myeloid Leukemia in...
www.infona.pl
Roberto Latagliata, Dario Ferrero, Alessandra Iurlo, Francesco Cavazzini, Fausto Castagnetti, Elisabetta Abruzzese, Carmen Fava, Massimo Breccia, Mario ...
Servizi Ambulatoriali – Ematologialasapienza.it
www.ematologialasapienza.it
Dal lunedì al venerdì dalle ore alle ore ; lunedì e giovedì dalle ore alle Per appuntamenti e comunicazioni. Telefonare dal lunedì al venerdì dalle ore alle al: – – Staff: Dott. Massimo BRECCIA Dott. Roberto LATAGLIATA Dott.
Jan 1, Mar 1, rd EHA Annual ...
sorted by relevance / date